Yuan Si

1.3k total citations
33 papers, 901 citations indexed

About

Yuan Si is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Yuan Si has authored 33 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Cell Biology and 8 papers in Cancer Research. Recurrent topics in Yuan Si's work include Hippo pathway signaling and YAP/TAZ (8 papers), Advances in Cucurbitaceae Research (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Yuan Si is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (8 papers), Advances in Cucurbitaceae Research (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Yuan Si collaborates with scholars based in China and United States. Yuan Si's co-authors include Te Zhang, Ying Liu, Yuchen Xiang, Xuewen Liu, Wenrong Xu, Wei Zhu, Fei Mao, Yongmin Yan, Hongxing Zhou and Huiling Cao and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Yuan Si

32 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Si China 18 521 215 191 107 100 33 901
Ya Gao China 20 491 0.9× 119 0.6× 200 1.0× 160 1.5× 127 1.3× 75 1.1k
Hitomi Fujisaki Japan 19 476 0.9× 174 0.8× 146 0.8× 111 1.0× 117 1.2× 60 1.0k
Yoshiki Mukudai Japan 17 579 1.1× 110 0.5× 199 1.0× 121 1.1× 69 0.7× 40 981
Zhen Gao China 22 437 0.8× 104 0.5× 223 1.2× 46 0.4× 85 0.8× 60 1.0k
Jeroen A.D.M. de Roos Netherlands 13 316 0.6× 133 0.6× 131 0.7× 155 1.4× 82 0.8× 15 795
Deema Hussein Saudi Arabia 15 858 1.6× 568 2.6× 180 0.9× 255 2.4× 63 0.6× 37 1.2k
Zeng Fan China 17 609 1.2× 87 0.4× 191 1.0× 278 2.6× 108 1.1× 62 1.2k
Moonmoon Deb India 23 873 1.7× 64 0.3× 258 1.4× 153 1.4× 55 0.6× 32 1.1k

Countries citing papers authored by Yuan Si

Since Specialization
Citations

This map shows the geographic impact of Yuan Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Si more than expected).

Fields of papers citing papers by Yuan Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Si. The network helps show where Yuan Si may publish in the future.

Co-authorship network of co-authors of Yuan Si

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Si. A scholar is included among the top collaborators of Yuan Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Si. Yuan Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hongli, Chongzhao You, Yixiao Zhang, et al.. (2025). Structural insights into antagonist recognition by the vasopressin V2 receptor. Nature Communications. 16(1). 9734–9734.
2.
Cao, Xiaolei, Fei Huang, Mei Tang, et al.. (2025). RIPK4 promotes epidermal differentiation through phase separation and activation of LATS1/2. Developmental Cell. 60(20). 2761–2776.e11. 1 indexed citations
3.
Chen, Qian, Yifan Zhong, Liang Zhang, et al.. (2025). Sculponeatin A induces mitochondrial dysfunction in non‐small cell lung cancer through WWP2‐mediated degradation of mitochondrial STAT3. British Journal of Pharmacology. 182(12). 2662–2681. 1 indexed citations
4.
Chen, Junjie, Yifan Zhong, Xuewen Liu, et al.. (2025). Liquid-liquid phase separation of GPS2-LATS1 promotes colorectal cancer progression by reprogramming lipid metabolism. Oncogene. 44(39). 3741–3754. 1 indexed citations
5.
Li, Fan, et al.. (2024). Towards a Future Hydrogen Supply Chain: A Review of Technologies and Challenges. Sustainability. 16(5). 1890–1890. 59 indexed citations
6.
Peng, Peng, Fangping Wan, Jie Shen, et al.. (2023). Sculponeatin A promotes the ETS1-SYVN1 interaction to induce SLC7A11/xCT-dependent ferroptosis in breast cancer. Phytomedicine. 117. 154921–154921. 20 indexed citations
8.
Chen, Junjie, Xuzhi Ruan, Qingqing Yu, et al.. (2023). Acetylation of MOB1 mediates polyphyllin II-reduced lysosome biogenesis in breast cancer by promoting the cytoplasmic retention of the YAP/TFEB coactivator complex. Phytomedicine. 122. 155152–155152. 7 indexed citations
9.
Xiang, Yuchen, Dan Yang, Xuzhi Ruan, et al.. (2023). Polyphyllin VII induces autophagy‐dependent ferroptosis in human gastric cancer through targeting T‐lymphokine‐activated killer cell‐originated protein kinase. Phytotherapy Research. 37(12). 5803–5820. 14 indexed citations
10.
Xiang, Yuchen, Peng Peng, Xuewen Liu, et al.. (2021). Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells. Acta Pharmacologica Sinica. 43(6). 1568–1580. 35 indexed citations
11.
Xiang, Yuchen, Jie Shen, Yuan Si, et al.. (2021). Paris saponin VII, a direct activator of AMPK, induces autophagy and exhibits therapeutic potential in non-small-cell lung cancer. Chinese Journal of Natural Medicines. 19(3). 195–204. 30 indexed citations
12.
Si, Yuan, Jiu Wang, Xuewen Liu, et al.. (2020). Ethoxysanguinarine, a Novel Direct Activator of AMP-Activated Protein Kinase, Induces Autophagy and Exhibits Therapeutic Potential in Breast Cancer Cells. Frontiers in Pharmacology. 10. 1503–1503. 34 indexed citations
13.
Xu, Jiaxin, Chen Yun-he, Rui Yang, et al.. (2020). Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity. Archives of Biochemistry and Biophysics. 684. 108314–108314. 44 indexed citations
14.
Si, Yuan, Yuchen Xiang, Zhou Tong, et al.. (2020). Polyphyllin I activates AMPK to suppress the growth of non-small-cell lung cancer via induction of autophagy. Archives of Biochemistry and Biophysics. 687. 108285–108285. 43 indexed citations
15.
Ma, Wenjing, Yuchen Xiang, Rui Yang, et al.. (2019). Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t(8;21) acute myeloid leukemia. Journal of Pharmacological Sciences. 139(4). 304–310. 28 indexed citations
16.
Fang, Ruihua, et al.. (2019). MicroRNA‐329 upregulation impairs the HMGB2/β‐catenin pathway and regulates cell biological behaviors in melanoma. Journal of Cellular Physiology. 234(12). 23518–23527. 24 indexed citations
17.
Liu, Huan, Xiaoming Dai, Xiaolei Cao, et al.. (2018). PRDM 4 mediates YAP ‐induced cell invasion by activating leukocyte‐specific integrin β2 expression. EMBO Reports. 19(6). 42 indexed citations
18.
Si, Yuan, Xinyan Ji, Xiaolei Cao, et al.. (2017). Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. Cancer Research. 77(18). 4868–4880. 117 indexed citations
19.
Zhu, Chu, Xinyan Ji, Haitao Zhang, et al.. (2017). Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway. Journal of Biological Chemistry. 293(4). 1178–1191. 43 indexed citations
20.
Yan, Yongmin, Wenrong Xu, Hui Qian, et al.. (2009). Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver International. 29(3). 356–365. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026